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Abstract: Women are more sensitive to most noxious visceral stimuli, both in terms of intensity and
frequency. The spinoparabrachial (spino-PBn) pathway is an essential neural circuit for the central
relay of viscerosensitive information, but studies characterizing the anatomical and physiological
characteristics of this pathway have only been conducted in males. Sex differences in the
anatomical and/or physiological organization of the spino-PBn may contribute to the sexually
dimorphic incidence rate

for visceral pain syndromes. Retrograde labeling and colorectal

distention (CRD) induced Fos expression was used to delineate the spino-PBn circuit in male and
cycling female Sprague-Dawley rats. The ability of morphine to suppress CRD was also examined.
Neurons retrogradely labeled from the PBn were localized primarily within the superficial dorsal
horn and sacral parasympathetic nucleus of the L5-S1 spinal cord. While no sex differences were
noted in either the distribution of spino-PBn neurons or in CRD-induced Fos expression,
significantly greater Fos expression was noted specifically in spino-PBn neurons in males
compared to females. Morphine selectively attenuated Fos expression in spino-PBn neurons in

males, but not females. Subsequent anatomical studies showed significantly reduced mu opioid
receptor protein levels and radioligand binding within the PBn of males in comparison to females.
Together, these data indicate that there are profound sex differences in how visceral pain and
opiates engage the spino-PBn pathway, which may account for the observed clinical differences in
visceral pain sensitivity and morphine antinociception.
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Editor, Special Issue, Physiology & Behavior
Dear Dr. Krause:
We submit the revised manuscript (PHB-D-08-00625), entitled:
"Sex differences in the activation of the spinoparabrachial circuit by visceral pain",
for publication in Physiology & Behavior, Special Issue on Sex Differences.
We were very pleased with the positive and thorough review of our manuscript, and are submitting a revised
version including all major and minor changes as recommended by the reviewers. A detailed list of all changes
with a brief summary of the reviewers comment followed by the authors’ response is given below.
Authors Response to Reviewers' comments:
Reviewer #1: General Comments:
Major Comments:
1. My only substantive suggestion is to pay at least 2-3 sentence lip service to the idea that other supraspinal
regions involved in endogenous analgesia may be involved as well as PbN…
Response: We now include a paragraph in the Discussion that addresses the role of the PAG and RVM, in
addition to the PBn.
2. "We have previously reported that in urethane anesthetized rats 30-40% of the lumbosacral dorsal horn
neurons retrogradely labeled from the PBn were Fos+ following noxious colorectal distention [15],
suggesting that visceral pain selectively activates the spinoparabrachial circuit." This, as stated, suggests
visceral pain activates the spinoparabrachial circuit but I do not see how this implies any selectivity, which
I take to mean that visceral pain but not superficial pain activates… Please clarify what is meant by
selectivity and how such selectivity is supported by data.
Response: The reviewer is correct and we cannot use the term ‘selectively’ since this was not specifically
addressed in that study. Therefore, we deleted the term ‘selectively’ and more accurately state that
‘visceral pain activates this circuit’.
3. "Indeed, we have recently reported that the ED50 for morphine is approximately two-times higher in
females than males in either visceral [24, 28, 29]." This sentence needs to be finished. And I would
recommend adding that these findings were from rats.
Response: The sentence is finished and the species indicated. I apologize for the sloppiness.
4. How many males, females were used in each expt? How many animals were studied after no
inflation/distension?
Response: n’s are now indicated.

5. The sections in Fig 6 so not appear representative of the data. It appears that the photo of a female PbN
shows much less than 50% of what the photo of a male PbN shows. Maybe the authors could add into the
legend what the optical densities of these two sections are so the reader can be calibrated.
Response: Optical density values are now indicated in Figure 6.
6. Minor comments
Response: All minor comments have been fixed.
Reviewer #2: Major Comments:
1. … Unfortunately, the female rat data for all but one part of the study was grouped together, thereby
weakening such an argument. How many rats were studied in each of the stages of the estrous cycle
(diestus, estrus, proestrus)? Were there differences among these female groups in terms of Fos+ cells,
FG+ cells, and double labeled cells? How do each of these groups compare to males?...
Response: Unfortunately, due to our small n’s, we were unable to analyze the female data in reference to
their stage of estrous. Following surgery, most of our animals remained in diestrus or proestrus, with very
few animals noted as being in estrus (n=1). We have now indicated this in the Discussion section and
referenced the Loyd et al. 2008 J. Neurosci paper for any discussion of hormonal influences on morphine
sensitivity.
2. Fluorogold injection into the parabrachial nucleus retrogradely labeled neurons at L5-S1 spinal levels that
were localized to lamina 1 and X and the sacral parasympathetic nucleus (SPN). Are you saying that there
are spino-PBn neurons in the SPN?? There should be a discussion of this finding, particularly given that
the sex difference was in part due to changes in activation of these neurons. Fluorogold is not known to
be a trans-synaptic tracer.
Response: We did note a few retrogradely labeled cells within the SPN (see Figure 6), however it was the
spino-PBn cells in lamina I that contributed to the observed sex differences in activation by noxious CRD
and suppression by morphine.
3. The Discussion is too short. Not much is there when you eliminate summary statements.
Response: The discussion was indeed remarkably short and has been ‘beefed’ up significantly.
4. Minor Edits
Response: All minor edits were fixed with the exception of encircling the PBn in Figure 1a and 1b. We
tried doing this and it looked horrible. The PBn is labeled, and we think the point is made that the
injection sites are comparable. As there were no sex differences noted in either the number of
retrogradely labeled neurons, or in their distribution, we felt that showing representative injection sites
was sufficient.
In summary, we would like to again thank the reviewers for taking the extensive time and effort to review our
manuscript. The reviews and comments were very thorough and highly constructive, and we feel that the
manuscript is much stronger with these revisions. We hope that you find our revised manuscript suitable for
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Abstract. Women are more sensitive to most noxious visceral stimuli, both in terms of
intensity and frequency. The spinoparabrachial (spino-PBn) pathway is an essential
neural circuit for the central relay of viscerosensitive information, but studies
characterizing the anatomical and physiological characteristics of this pathway have
only been conducted in males. Sex differences in the anatomical and/or physiological
organization of the spino-PBn may contribute to the sexually dimorphic incidence rate
for visceral pain syndromes. Retrograde labeling and colorectal distention (CRD)
induced Fos expression was used to delineate the spino-PBn circuit in male and cycling
female Sprague-Dawley rats. The ability of morphine to suppress CRD was also
examined. Neurons retrogradely labeled from the PBn were localized primarily within
the superficial dorsal horn and sacral parasympathetic nucleus of the L5-S1 spinal cord.
While no sex differences were noted in either the distribution of spino-PBn neurons or in
CRD-induced Fos expression, significantly greater Fos expression was noted
specifically in spino-PBn neurons in males compared to females. Morphine selectively
attenuated Fos expression in spino-PBn neurons in males, but not females. Subsequent
anatomical studies showed significantly reduced mu opioid receptor protein levels and
radioligand binding within the PBn of males in comparison to females. Together, these
data indicate that there are profound sex differences in how a noxious visceral stimulus
and opiates engage the spino-PBn pathway, which may account for the observed
clinical differences in visceral pain sensitivity and morphine antinociception.
Indexing Terms: colorectal distension, parabrachial nucleus, opiates, mu opioid
receptor, morphine
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Pain of visceral origin is a significant problem, both in terms of management and
how it affects quality of life. It is the defining characteristic of functional bowel disorders,
including irritable bowel syndrome (IBS), functional dyspepsia, ulcerative colitis, and
acute and chronic pancreatic disease to name a few. Epidemiological studies have
consistently shown that women are more likely to suffer from visceral pain than men [14].

Unfortunately, very little, if anything, is known regarding the etiology of these sex

differences. Using colorectal distension as a model of visceral pain, we have recently
shown that females have significantly lower visceral pain thresholds than males [5]. Our
data further suggest that the gonadal steroid estradiol contributes to the observed sex
differences in visceral sensitivity [5-7]. However, the anatomical and physiological basis
for sexually dimorphic visceral pain thresholds is not known.
The parabrachial nucleus (PBN) has long been recognized as an important
brainstem relay in visceral nociceptive sensory processing [8-10]. Nociceptive dorsal
horn neurons, most notably from lamina I, project to the PBn [11-15] and relay noxious
visceral input to the lateral parabrachial nuclei including the external, superior, dorsal
and central lateral subnuclei [16, 17]. Neurons in the parabrachial nuclei that respond to
noxious stimulation, in turn, project to the central nucleus of the amygdala [8, 18, 19], and
this spino-parabrachial-amygdala pathway is thought to constitute an essential circuit for
the affective-motivational component of visceral pain [18].
Lumbosacral spinal cord neurons retrogradely labeled from the PBn are located
predominantly within lamina I and the lateral reticulated area of the neck of the dorsal
horn. We have previously reported that in urethane anesthetized rats 30-40% of the
lumbosacral dorsal horn neurons retrogradely labeled from the PBn were Fos+ following
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noxious colorectal distention [15], suggesting that visceral pain activates the
spinoparabrachial circuit. These studies were conducted in males and comparable
studies have not been conducted in females even though the incidence rate for most
visceral pain syndromes is significantly higher in females [1].
It is well established that systemic or central opioid administration significantly
attenuates visceral pain. Indeed, opioid-based narcotics have long been recognized as
the drug of choice for the attenuation of postoperative, obstetric and cancer pain that is
visceral in origin [20-22]. Several studies have reported that intrathecally or systemically
administered mu, delta or kappa agonists significantly attenuate both the visceromotor
reflex and the pressor reflex evoked by CRD (rat: 6, 8, 18, 19, 23, 24; rabbit: 27, 28). Similar
results have been reported using the acetic acid writhing test [25-27].
While the above studies indicate that morphine is an effective drug for the alleviation
of visceral pain, it is becoming increasingly clear that there are profound sex differences
in the antinociceptive potency of opioids. Indeed, we have recently reported that the
ED50 for morphine is approximately two-times higher in female than male rats in either

visceral [6, 24, 28] or persistent somatic [29, 37] pain assays. However, the locus for
morphine suppression of visceral pain is unclear. Mu opioid receptors (MOR) are
extremely dense within the rat dorsal horn and overlap with the distribution of spino-PBn
neurons. However, as there are no sex differences in spinal morphine antinociception of
CRD, suggesting that the spinal cord dorsal horn is not the locus underlying the sexually
dimorphic actions of morphine [24]. Alternatively, MOR expression is extremely dense
within the PBN, and overlaps with the distribution of spino-PBn afferents [30, 31]. Sex
differences in morphine inhibition of visceroceptive input to the PBn would provide a
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direct mechanism for the sexually dimorphic effects of morphine on visceral pain
modulation.
The present study tested the hypothesis that sex differences in the anatomical
organization of the spino-PBn circuit, and its activation by a noxious visceral stimulus,
provide the biological bases for the observed sex differences in visceral pain. We also
tested whether systemic administration of morphine differentially suppressed the
activation of this pathway in male and female rats. Additional studies tested the
hypothesis that sex differences in PBn MOR protein levels and binding contributed to
the dimorphic effects of morphine observed in the present study.
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MATERIALS AND METHODS

Experimental Subjects. Eighteen adult intact male Sprague-Dawley rats and eighteen
adult cycling female Sprague-Dawley rats (Zivic-Miller) were used in these experiments.
Animals were weight-matched (250-300g) and housed in same-sex pairs in separate
rooms on a 12:12 hour light: dark cycle (lights on at 7:00A.M.). Rats had access to food
and water ad libitum. These studies were performed in strict compliance with the
Institutional Animal Care and Use Committee at Georgia State University. All efforts
were made to minimize any possible suffering by the animal, and to reduce the number
of animals used.
Vaginal Cytology. Vaginal lavages were performed daily beginning two weeks prior to
testing to confirm that all female rats were cycling normally and to keep daily records on
the stages of their cycle in respect to experimental testing. Proestrus was identified as a
predominance of nucleated epithelial cells and estrus was identified as a predominance
of cornified epithelial cells [58]. Diestrus 1 was differentiated from Diestrus 2 by the
presence of leukocytes. As no differences were noted between Diestrus 1 and Diestrus
2 animals on any of our dependent measures, these groups are pooled (Diestrus). Rats
that appeared between phases were noted as being in the more advanced stage.
Iontophoresis Injections. Male and female rats were anesthetized with
ketamine/xylazine (50 mg/kg / 10mg/kg; s.c.) and placed in a stereotaxic frame upon
achieving a deep surgical plane of anesthesia as previously described [15]. The skull
was adjusted so that bregma and lambda were at the same dorsoventral coordinate. A
glass micropipette (tip: 10-20 µM) was filled with the retrograde tracer Fluorogold (FG;
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2% soln. w/v in saline; Fluorochrome Inc.) via capillary action and lowered into the
parabrachial nucleus at the following coordinates (in mm): Lambda: -0.5; ML: 1.8; DV:
5.0 from brain. FG was iontophoresed (50/50 duty cycle, 7.5 A current) for 15 min.
Pipettes remained in place for five minutes after injection to prevent backflow of tracer
along the pipette tract and to facilitate neuronal uptake. Attention to detail was taken to
ensure that all injection protocols were comparable for males and females. Following
surgery the animals recovered under a heat lamp and were returned to their original
housing facilities upon recovery from the anesthetic.
Colorectal Distension & Morphine Administration. Animals were fasted 24 hrs prior
to the experiment; water was provided ad libitum. On the day of the experiment, rats
were briefly sedated with isofluorane and a 5-6 cm balloon attached to Tygon tubing
was inserted through the anus into the descending colon and rectum. The distal end of
the balloon was at least 1 cm proximal to the external anal sphincter. Rats were loosely
restrained and allowed 30 min to recover from the isofluorane. Colorectal distention
(CRD) was produced by inflation of the distention balloon with air. The pressure was
monitored and kept constant by a pressure controller/timing device (Bioengineering,
University of Iowa). Rats (male, n=16; females, n=16) were distended to 80 mmHg
(noxious) for two hours (30 sec on; 90 sec off) and then perfused [32]. Control animals
(n=2/sex) were treated identical to the experimental groups except that the balloon was
not inflated.
Immediately prior to distention, animals were administered morphine sulfate
subcutaneously (4.0 mg/kg, s.c.; 28, 34) or equivolume of sterile saline as a control.
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Morphine sulfate, a gift from the NIDA Drug program, was prepared fresh in sterile
saline on the day of the experiment.
Perfusion fixation. Two hours after morphine administration, animals were given a
euthanizing dose of Nembutal (160 mg/kg; i.p.) and perfused transcardially with 150200 ml of 0.9% sodium chloride containing 2% sodium nitrite as a vasodilator, followed
immediately by 300 ml of 4% paraformaldehyde in 0.1M phosphate buffer containing
2.5% acrolein (Polyscience). Residual acrolein was removed from the animal with a
final rinse with 150-200 ml of the sodium chloride/sodium nitrate solution. The brain and
spinal cord were removed immediately following perfusion and the tissue was stored at
4°C in 30% sucrose solution. Tissue was cut into 25m coronal sections with a Leica
2000R freezing microtome and stored free-floating in cryoprotectant-antifreeze solution
[33]

at –20°C until immunocytochemical processing was initiated.

Immunocytochemistry. Brain (1:6 series) and lumbosacral spinal cord (L5-S1; 1:4
series) were processed for FG and/or Fos immunoreactivity as previously described [28,
34].

Briefly, sections were removed from the cryoprotectant-antifreeze solution, rinsed

extensively in potassium phosphate-buffered saline (KPBS), and then reacted for 20
minutes in 1% sodium borohydride to remove excess aldehydes. Sections were then
incubated in primary antibody solution directed against either Fos or FG in KPBS
containing 0.1% Triton X for 1 hour at room temperature followed by 48 hours at 4C.
Cells containing Fos were identified using the polyclonal rabbit anti-Fos antibody
(Oncogene, Cat. No. PC38; lot no. 4194) at a concentration of 1:50,000. This rabbit
antiserum was prepared against the synthetic peptide (SGFNADYEASSSRC)
corresponding to amino acids 4-17 of human c-Fos. In western blots, this antibody
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recognizes the ~55 kDa c-Fos and ~62 kDa v-Fos proteins, and does not cross-react
with the ~39 kDa Jun protein (manufacturer’s technical information). FG containing cells
were recognized using the polyclonal rabbit anti-Fluorogold antibody (Chemicon, Cat.
No. AB153; lot no. 25060005) at a concentration of 1:10,000. This antibody was raised
against the chemical compound hydroxystildamidine. No cytoplasmic FG staining was
present in animals in which the tracer failed to be ejected from the electrode. In addition,
the distribution of retrogradely labeled cells within the dorsal horn of the spinal cord is
identical to published reports using alternative retrograde tracers.
After rinsing in KPBS, the tissue was incubated for 1 hour in biotinylated goat antirabbit IgG (Jackson Immunoresearch, 1:600), rinsed in KPBS, and incubated for 1 hour
in avidin-biotin peroxidase complex (1:10; ABC Elite Kit, Vector Labs). After rinsing in
KPBS and sodium acetate (0.175 M; pH 6.5), Fos was visualized as a black reaction
product using nickel sulfate intensified 3,3’-diaminobenzidine solution containing 0.08%
hydrogen peroxide in sodium acetate buffer. FG was always visualized as a brown
reaction product using 3,3’-diaminobenzidine containing 0.08% hydrogen peroxide in
Tris buffer (pH 7.2). The reaction product was terminated after 15-30 minutes by rinsing
in sodium acetate buffer.
For labeling both antigens, sections were first processed for Fos immunoreactivity as
described above producing a black reaction product. Following visualization of Fos,
sections were rinsed in KPBS and then processed as above with the rabbit anti-FG
producing a brown reaction product. Resulting double labeled neurons had black nuclei
[35]

surrounded by brown cytoplasm (FG) [15, 28]. Sections were mounted out of saline
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onto gelatin-subbed slides, air-dried overnight, dehydrated in a series of graded
alcohols, cleared in xylene, and cover-slipped using Permount.
For identification of mu opioid receptor containing neurons, 25 um tissue sections
were incubated in primary antibody solution rabbit anti-MOR1 (Abcam, Cambridge, MA;
1,50,000) in KPBS containing 1.0% Triton-X for one hour at room temperature followed
by 48 hours at 4C. This antibody was prepared against the synthetic peptide
(NHQLENLEAETAPLP) corresponding to amino acids 384-398 of rat MOR1 [36].
Secondary and avidin-biotin-peroxidase steps were identical to above. MOR1 was
visualized as a black reaction product using nickel sulfate intensified 3,3’diaminobenzidine solution containing 0.08% hydrogen peroxide in sodium acetate
buffer. Sections were rinsed, mounted and dehydrated in a series of graded alcohols,
and then cover-slipped using Permount. Mu opioid receptor antibody specificity was
confirmed by lack of MOR+ labeling in MOR knock out mouse tissue (kindly provided by
Bridgette Kieffer, Ph.D., Institut de Génétique et de Biologie Moléculaire et Cellulaire,
Illkirch, France).
Receptor Autoradiography. Intact male (n=4) and cycling female rats (n=4) were
rapidly decapitated and brains prepared for autoradiography as previously described
[37].

Briefly, brains were removed rapidly, flash frozen in 2-Methylbutane and stored at -

80oC. Fresh frozen tissue was cut in a 1:4 series of 30 m coronal sections at -20 oC
with a Leica CM3050S cryostat, immediately mounted onto glass slides and stored at 80oC. Slides were dried and fixed in 4% paraformaldehyde followed by rinses in 50mM
Tris buffer (pH 7.4) containing 100nM NaCl. Slides were then placed in a tracer buffer
containing either tritiated DAMGO (1 nM; Amersham, Pittsburg, PA) or tritiated
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Naloxone (0.5 nM; Amersham, Pittsburg, PA) for 60 minutes followed by a series of
rinses in 50mM Tris buffer (pH 7.4) containing MgCl2. Tissue was allowed to dry and
placed on autoradiographic film for 5 weeks at which point films were developed with a
FujiFilm BAS 5000 (Valhalla, NY).
Densitometry. For MOR immunohistochemistry data, 12-bit grayscale images were
captured using a QImaging Retiga EXi CCD camera (Surrey, BC, Canada) and IPLab
Image Analysis Software (BD Biosciences, Rockville, MD). The PBn was bilaterally
sampled (35mm2 at 10X magnification) between Bregma -9.16 to -9.68 three times per
section and the average grayscale pixel value across the PBn (mean 6 sections per
subject) was recorded. Measures were corrected for non-specific immunoreactivity
background by subtraction of measures taken from areas of equal size lacking specific
immunoreactivity adjacent to the PBn in the same section. For autoradiography data,
color images were captured and the brightness/contrast was adjusted using Fujifilm
Multigauge software (Vallhala, NY). Measures were corrected for non-specific binding
by subtraction of measures taken from a same section area adjacent to the PBn of
equal size.
Data Analysis and Presentation. The mean number of FG+, Fos+, or Fos+FG
neurons was determined for three rostrocaudal levels of the spinal cord: L5, L6 and S1.
These regions are easily distinguishable based on the following anatomical landmarks:
L5 contains a prominent lateral column of motor neurons; L6 contains the
retrodorsolateral (RDL) motoneuronal pool; S1 was defined as the absence of the RDL
and the presence of the sacral parasympathetic nucleus (SPN) [38, 39]. The number of
singly (FG or Fos) or dually (FG that contained Fos; FG/Fos) labeled cells was for
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quantified for 5-6 sections per region per animal. The number of Fos+ cells within the
PBn was also quantified on the side contra to the injection site using the above
procedure. Results are expressed as the mean + standard error of the mean. Only
animals with comparable injection sites limited to the PBn were used for analysis
(males, n=12; females, n=10). Analysis of variance was used to test for significant main
effects of sex (male, female) and treatment (morphine, saline). P<0.05 was considered
significant for all analyses.
For data presentation, a representative animal from each experimental group was
selected and the distributions of FG and Fos within the L5-S1 spinal cord were plotted
using a Nikon Drawing Tube attached to a Nikon Optiphot microscope. Plots were
imported to the computer and finalized using Adobe Illustrator 10. Photomicrographs
were generated using a Synsys digital camera attached to a Nikon Eclipse E800
microscope. Images were captured with IP Spectrum software and finalized using
Adobe Photoshop 7.0. Alterations to the images were strictly limited to enhancement of
brightness/contrast.
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RESULTS
Anatomical and Functional Organization of the Spino-Parabrachial Circuit
The first series of experiments tested the hypothesis that sex differences in the anatomy
and/or physiology of the spino-PBn pathway contributed to the previously observed sex
differences in visceral sensitivity [24]. Figure 1 shows examples of a Fluorogold (FG)
injections into the PBn. Spino-PBn neurons were localized within L5-S1 spinal cord, in
lamina I and X, and the sacral parasympathetic nucleus (SPN). No sex differences were
noted in either the distribution or number of FG+ cells, with an average of 10-15
retrogradely labeled cells per section (see Fig. 2A,B). Interestingly, while colorectal
distention induced comparable Fos expression in the L5-S1 cord of males and females
(mean cells/section for combined L5-S1: males, 79+7; females, 92+4; Fig. 2A, right
panel and Fig. 2B), noxious CRD selectively activated spino-PBn neurons in males, but
not females (Fig. 2C). Indeed, in males, approximately 70% of spino-PBn neurons
expressed CRD-induced Fos; by contrast, less than 40% of spino-PBn neurons were
Fos+ in females. Dual labeled cells were localized primarily within lamina I and SPN
(Fig. 2B). Limited Fos expression was observed in control animals that did not undergo
distension. Figure 3 shows an example of the high level of Fos expression in spino-PBn
neurons in males versus females. These studies are the first to demonstrate sex
differences in the activation of a visceral pain pathway; this sexually dimorphic
activation of the spino-PBn circuit may provide the biological basis for our observed sex
differences in visceral sensitivity.
Morphine differentially modulates visceral sensitivity in males and females.

13

In our previous studies, we found that systemic administration of morphine differentially
suppressed the magnitude of the visceromotor response to CRD (ED50: 3.8 for females
vs. 1.5 mg/kg for males [24]). Given these significant sex differences in morphine
attenuation of visceral pain, we next examined whether morphine preferentially
suppressed CRD-induced Fos in spino-PBn neurons. As shown in Figure 4, morphine
significantly suppressed CRD-induced Fos in males (p<0.0001) but not females
(p>0.05). Similar to previous reports [42], morphine suppressed CRD-induced Fos in all
laminar regions (Fig. 4B). Interestingly, the percentage of spino-PBn neurons
expressing Fos was reduced from 70% to 40% in males, while no reduction in FG/Fos+
neurons was noted for females (Fig. 4C). Representative photomicrographs showing
the sex difference in morphine suppression of CRD-induced Fos in spino-PBn neurons
are shown in Figure 5.
Sex differences in mu opioid receptor expression in the PBn
In the present study, morphine was given systemically and therefore may be acting
peripherally and/or centrally to suppress CRD-induced Fos and visceral pain. The
lumbosacral dorsal horn and PBn are two likely sites for morphine action: both contain
high levels of MOR and respond to noxious visceroceptive input. As we have previously
shown no sex differences in spinal morphine suppression of visceral pain [24], our next
series of experiments focused on the PBn, specifically examining whether MOR
expression within the PBn was sexually dimorphic and may contribute to the observed
sex differences in morphine suppression of visceral pain.
MOR immunoreactivity was extremely dense throughout the PBn, and was present
in all PBn subnuclei. Figure 6 shows an example of MOR+ staining within the PBn of a
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male (Fig. 6A) and diestrus female (Fig. 6B) rat. MOR expression fluctuated across the
estrous cycle, with significantly reduced MOR immunoreactivity noted in proestrus
females when compared males (p=0.007). This reduction in MOR expression in
proestrus females was not limited to any particular subnuclei but was uniformly reduced
throughout the PBn.
We next used autoradiography to determine if the sex differences in PBn MOR
immunoreactivity were reflected as a decrease in ligand binding. Figure 7 shows
representative autoradiograms of a male (Fig. 7A) and diestrus female (Fig. 7B).
Quantitative analysis of tritiated DAMGO binding showed significantly reduced binding
within the PBn of diestrus females compared to males (p=0.04).
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Discussion
The present study tested the hypothesis that sex differences in the anatomy
and/or physiology of the spino-PBn pathway contribute to sex differences in visceral
pain. Two key observations are reported. First, no sex difference was observed in either
the number or distribution of CRD-evoked Fos labeled neurons in the spinal cord, or in
the number or distribution of spinal neurons retrogradely labeled from the PBn.
However, noxious CRD preferentially activated the spino-PBn pathway in males, but not
females. In contrast, the response of postsynaptic dorsal column neurons to noxious
visceral stimulation is greater in females compared to males [55], suggesting that
supraspinal relay of visceroceptive information is sexually dimorphic. These findings
have significant implications for therapeutic strategies designed to suppress visceral
pain.
The second major finding of these studies is that systemic morphine produced
greater attenuation of CRD-induced Fos expression in the lumbosacral spinal cord in
general, and spino-PBn neurons in particular, in male rats. This finding is consistent
with previous studies reporting greater morphine antinociception in males compared to
females [37, 44-46]. Indeed, we have recently reported that systemic,
intracerebroventricular or intra-PAG morphine produces greater attenuation of visceral
and persistent somatic inflammatory pain in male compared to female rats [24, 37].
Interestingly, the sex difference in the effect of morphine on the visceromotor response
was not mediated at the level of the spinal cord as we have previously reported no sex
difference following intrathecal morphine, although there was significant antinociception
[24].

On the other hand, intracerebroventricular injection of morphine attenuated the
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visceromotor response to a greater extent in male rats, suggesting supraspinal
processing underlies the observed sex difference [37, 59, 60].
The present data are consistent with the hypothesis that the spino-PBn pathway
contributes to the sex difference in CRD-evoked visceromotor response by more
effectively activating a descending opioidergic inhibitory circuit in males. The PBn
contains a dense population of both mu and delta opioid receptor immunoreactive
fibers, as well as their respective endogenous ligands, endomorphin and enkephalin [10,
31, 49-51].

Activation of the spino-PBn pathway has been shown to modulate visceral

pain, presumably via the release of endogenous opioids. Therefore, activation of the
spino-PBn circuit by noxious colorectal distension would have the end result of
decreasing visceral pain sensitivity. However, noxious CRD did not activate this circuit
in females, and suggests that the failure of a noxious visceral stimulus to activate the
spino-PBn pathway contributes to the overall increased visceral pain sensitivity
observed in females.
In addition to the PBn, other brain regions may also contribute to the observed
differences in viscerosensitivity and morphine analgesia noted in the present study,
including the midbrain periaqueductal gray (PAG) and the rostral ventromedial medulla
(RVM) which includes the nucleus raphe magnus. Indeed, the PAG, and its descending
projections to the RVM and spinal cord constitute an essential pathway for the painsuppressing effects of both exogenous and endogenous opiates. Similar to the PBn,
sex differences in MOR expression have been reported within the PAG, with males
having 1.5-fold higher levels than females [37]. In addition, persistent inflammatory pain
has been shown to selectively activate the PAG-RVM pathway in males, but not
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females [28, 59]. Together with the present data, this suggests that sex differences in
the anatomical and physiological organization of pain pathways may be more common
than previously realized, and highlights the need for the inclusion of female subjects in
all experimental studies examining the biological bases of somatic, visceral or orofacial
pain.
There are several additional mechanisms that may also contribute to the observed
sex differences in morphine suppression of visceral pain. First, we show for the first time
that overall, males have significantly higher levels of [3H]DAMGO binding within the
PBn than females. Similarly, we show that MOR protein levels fluctuate across the
estrous cycle, with overall lower levels of MOR immunoreactivity observed in females
than males. As estradiol has been shown to induce rapid MOR internalization, thereby
reducing available MOR for ligand binding [52,53], these results are not surprising.
Estradiol has also been shown to uncouple MOR from GIRK channels [54], which would
account for the decreased efficacy of morphine observed in the present study. Similar
findings demonstrating reduced morphine potency during proestrus have also been
reported following intra-PAG opiate administration [37]. Unfortunately, in our behavioral
studies, we were not able to examine the impact of estrous on visceral sensitivity and
activation of the spino-PBn pathway due to low numbers of animals in all three stages
(estrus, diestrus and proestus).
As discussed above, the results of the present study parallel our recent findings
demonstrating significantly higher levels of MOR immunoreactivity and binding within
the PAG of male versus female rats [37]. Together, these studies suggest that, overall,
females have lower levels of MOR within several key pain-related brain regions which
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likely provide the biological bases for the sexually dimorphic action of morphine. These
results further suggest that morphine may not be the drug of choice for the modulation
of pain in females. Clearly, additional studies are warranted.
In summary, epidemiological studies have consistently shown that women are more
likely to suffer from visceral pain than men [1]. Unfortunately, very little, if anything, is
known regarding the etiology of these sex differences [21, 55-57]. The results of the
present study demonstrate for the first time that noxious visceral stimulation selectively
activates the spino-PBn pathway in males; as activation of this pathway would likely
result in the release of endogenous opioid peptides in order to modulate the visceral
pain, these studies suggest a potential anatomical circuit underlying sex differences in
visceral pain.
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Figure Legends
Figure 1. Photomicrographs of Fluorogold (FG) injections into the PBn of male (A) and
female (B) rats. LTDg, Laterodorsal tegmental nucleus; scp, superior cerebellar
peduncle; Mo5, trigeminal motor nucleus.
Figure 2. (A) Mean number of retrogradely labeled neurons observed within the L5-S1
spinal cord following FG injection into the PBn of a male and female rat (left panel). The
right panels show the mean number of Fos+ cells localized within the L5-S1 spinal cord
following colorectal distention or control. (B) Representative plot of the distribution of
FG+ cells (black) and Fos+ cells (grey) within the male and female L6 spinal cord
following colorectal distension. Each dot represents one cell. (C) Percentage of spinoparabrachial neurons that contained Fos following noxious colorectal distention. Error
bars represent S.E.M.
Figure 3. Photomicrograph of the spinal cord dorsal horn showing examples of
neurons retrogradely labeled from the parabrachial nucleus (FG; brown), neurons
expressing CRD-induced Fos (black) and dual labeled cells (FG+Fos; indicated by red
arrows) in males (A) and diestrus females (B).
Figure 4. (A) Mean number of L5-S1 dorsal horn neurons expressing CRD-induced
Fos following administration of saline or morphine in male and female rats. (B)
Representative plots of the distribution of FG+ cells (black) and CRD-induced Fos (grey)
within the male and female L6 spinal cord following administration of morphine. Each
dot represents one cell. (C) Percentage of spino-parabrachial neurons that expressed
CRD-induced Fos following administration of saline or morphine in males and females.
Error bars represent S.E.M.
Figure 5. Representative photomicrographs of CRD-induced Fos (black dots) in the L6
spinal cord following administration of saline or morphine in male and female rats.
Figure 6. Mu opioid receptor expression within the parabrachial nucleus of the male (A)
and female (B) rat. (C) Densitometric analysis of the mean optical density of PBn MOR
immunocytochemistry showed a significant reduction of MOR in proestrus females in
comparison to males. vsc, ventral spinocerebellar tract; scp, superior cerebellar
peduncle; MO5, trigeminal motor nucleus; LPBv, lateral parabrachial nucleus, ventral;
MPBe, Medial parabrachial nucleus, external; LPBc, lateral parabrachial nucleus,
central LPBe, lateral parabrachial nucleus, external; ovx, ovariectomized; Di, diestrus;
Pro, proestrus; Est, estrus. Error bars represent S.E.M. Optical density level for male =
526; for female = 364. * indicates a significant mean difference, p<0.05.
Figure 7. Photomicrograph depicting [3H]DAMGO receptor binding within the
parabrachial nucleus of a male (A) and female (B) rat. (C) Optical density values of
[3H]DAMGO binding within the PBn of males and females. Error bars represent S.E.M.
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